BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

MMS Holdings, Inc. Adds Greg Burkhart, M.D. and Brent Blumenstein, Ph.D. to Its DSMB Leadership


9/10/2012 10:36:41 AM

Canton, MI (September 10, 2012) - MMS Holdings Inc. announced today that they have added Dr. Greg Burkhart and Dr. Brent Blumenstein to its Data and Safety Monitoring Board (DSMB) leadership.

Dr. Burkhart is well known for his expertise with DSMBs and multiple data analyses formats as well as his experience in epidemiology. While serving on the MMS DSMB, he will work to provide sponsors with a seamless output across their programs and facilitate value-added discussions at the DSMB meetings.

Dr. Blumenstein brings 35 years of statistical experience along with expertise in agency preferences and best practices for our client’s portfolio’s. Drs. Burkhart and Blumenstein have worked together for many years and will bring to the MMS DSMB team their experiences and insights into current trends in the industry.

“Greg and Brent bring valuable leadership and expertise to our team.” Says Dr. Ethan Weiner, leader of DSMB efforts at MMS.

“Their experience will benefit clients and staff across many programs.”

For a brief biography of our newest DSMB leadership please go to: http://www.mmsholdings.com/clinical-leadership.htm. MMS Holdings Inc. is a highly experienced pharmaceutical service organization, based in Canton Michigan, that is focused on quality deliverables in the areas of clinical programming, biostatistics, medical and regulatory writing, pharmacovigilance, clinical trial disclosure, data abstraction, and data management. Our DSMB serves several clients across therapeutic areas and we support all aspects of the DSMB including working with academic expertise. Commitment to quality deliverables with robust submission experience sets MMS apart from traditional service providers. MMS Holdings Inc. is ISO 9001:2008 certified for all services and maintains detailed quality metrics for every project.

For more information visit http://www.mmsholdings.com.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->